|
| |
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online July 23, 2003
Review Article |
Evolution of the coordinate regulation of glycolytic enzyme genes by hypoxia
Department of Molecular and Cellular Pharmacology, University of Miami Medical Center, Miami, FL 33136, USA e-mail: kwebster{at}chroma.med.miami.edu
Accepted 27 May 2003
Two billion years of aerobic evolution have resulted in mammalian cells and tissues that are extremely oxygen-dependent. Exposure to oxygen tensions outside the relatively narrow physiological range results in cellular stress and toxicity. Consequently, hypoxia features prominently in many human diseases, particularly those associated with blood and vascular disorders, including all forms of anemia and ischemia. Bioenergetic enzymes have evolved both acute and chronic oxygen sensing mechanisms to buffer changes of oxygen tension; at normal PO oxidative phosphorylation is the principal energy supply for eukaryotic cells, but when the PO falls below a critical mark metabolic switches turn off mitochondrial electron transport and activate anaerobic glycolysis. Without this switch cells would suffer an immediate energy deficit and death at low PO. An intriguing feature of the switching is that the same conditions that regulate energy metabolism also regulate bioenergetic genes, so that enzyme activity and transcription are regulated simultaneously, albeit with different time courses and signaling pathways. In this review we explore the pathways mediating hypoxia-regulated glycolytic enzyme gene expression, focusing on their atavistic traits and evolution.
Key words: hypoxia, anaerobic, glycolysis, gene expression, HIF-1, evolution
Related articles in JEB:
This article has been cited by other articles:
|
|
 |
|
  M. Fluck, K. A. Webster, J. Graham, F. Giomi, F. Gerlach, and A. Schmitz Coping with cyclic oxygen availability: evolutionary aspects Integr. Comp. Biol., October 1, 2007; 47(4): 524 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hoogewijs, N. B. Terwilliger, K. A. Webster, J. A. Powell-Coffman, S. Tokishita, H. Yamagata, T. Hankeln, T. Burmester, K. T. Rytkonen, M. Nikinmaa, et al. From critters to cancers: bridging comparative and clinical research on oxygen sensing, HIF signaling, and adaptations towards hypoxia Integr. Comp. Biol., October 1, 2007; 47(4): 552 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Martinez, C. Landry, R. Boehm, S. Manning, A. O. Cheek, and B. B. Rees Effects of long-term hypoxia on enzymes of carbohydrate metabolism in the Gulf killifish, Fundulus grandis J. Exp. Biol., October 1, 2006; 209(19): 3851 - 3861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Wilhide and W. K. Jones Potential Therapeutic Gene for the Treatment of Ischemic Disease: Ad2/Hypoxia-Inducible Factor-1{alpha} (HIF-1)/VP16 Enhances B-Type Natriuretic Peptide Gene Expression via a HIF-1-Responsive Element Mol. Pharmacol., June 1, 2006; 69(6): 1773 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nikinmaa and B. B. Rees Oxygen-dependent gene expression in fishes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1079 - R1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Ratan, A. Siddiq, L. Aminova, P. S. Lange, B. Langley, I. Ayoub, J. Gensert, and J. Chavez Translation of Ischemic Preconditioning to the Patient: Prolyl Hydroxylase Inhibition and Hypoxia Inducible Factor-1 as Novel Targets for Stroke Therapy Stroke, November 1, 2004; 35(11_suppl_1): 2687 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Phillips BREATHLESS THROUGH THE AGES J. Exp. Biol., September 1, 2003; 206(17): 2903 - 2904. [Full Text] [PDF]
|
|
